Are human endogenous retrovirus K ( HML-2 ) Gag and Env specific T-cell responses detected in HTLV-I-infected subjects using standard peptide screening methods?
Thus, although the limited scope of our screening prevents us from conclusively disproving our hypothesis, the current study does not provide data supporting a role for HERV-specific T-cell responses in HTLV-1 associated immunopathology.
The prophylactic administration of daclizumab improved early graft survival and prevented irreversible acute rejection.